本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国血液技术

49.99
+0.55001.11%
盘后49.990.00000.00%18:02 EDT
成交量:65.02万
成交额:3,245.97万
市值:24.08亿
市盈率:15.26
高:50.27
开:49.30
低:49.12
收:49.44
52周最高:94.99
52周最低:47.32
股本:4,817.73万
流通股本:4,759.82万
量比:1.63
换手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):3.28
每股收益(LYR):3.33
净资产收益率:18.27%
总资产收益率:6.52%
市净率:2.73
市盈率(LYR):15.00

数据加载中...

2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/05/11

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

重要事件披露

8-K - Current report
2023/02/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/10/19

重要事件披露

8-K - Current report